- ►diabetesjournals.org E Ferrannini, G Mingrone - Diabetes care, 2009 - Am Diabetes Assoc The prevalence of obesity appears to have reached a plateau in the US between 2003 and 2007
(1), but the obesity epidemic is still rampant in many other countries—especially in the developing
world (2)—in adults as well as children (http://www.who.int/topics/obesity/en/). A recent ... Cited by 6 - Related articles - All 4 versions
R Murphy, A Tura, PM Clark, JJ Holst, A Mari, AT … - Diabetologia, 2009 - Springer Abstract Aims/hypothesis The incretin hormones glucagon-like pep- tide-1 (GLP-1) and
glucose-dependent insulinotrophic peptide (GIP) are released from intestinal endocrine cells
in response to luminal glucose. Glucokinase is present in these cells and has been ... Cited by 4 - Related articles - All 2 versions
GE Lim, GJ Huang, N Flora, D LeRoith, CJ Rhodes, PL … - Endocrinology, 2009 - Endocrine Soc Insulin resistance and type 2 diabetes mellitus are associated with impaired postprandial secretion
of glucagon-like peptide-1 (GLP-1), a potent insulinotropic hormone. The direct effects of insulin
and insulin resistance on the L cell are unknown. We therefore hypothesized that the L ... Cited by 5 - Related articles - All 3 versions
G Mingrone, G Nolfe, G Castagneto Gissey, A Iaconelli, … - Diabetologia, 2009 - Springer Abstract Aims/hypothesis We tested the hypothesis that the revers- ibility of insulin resistance
and diabetes observed after biliopancreatic diversion (BPD) is related to changes in circadian
rhythms of gastrointestinal hormones. Methods Ten morbidly obese participants, five with ... Cited by 3 - Related articles - All 2 versions
J Korner, W Inabnet, G Febres, IM Conwell, DJ … - International Journal of …, 2009 - nature.com The objective of this study was to quantify hormones that regulate energy and glucose homeostasis
to establish possible mechanisms for the greater efficacy of Roux-en-Y gastric bypass
(RYGB) compared with laparoscopic adjustable gastric banding (LAGB) in achieving ... Cited by 4 - Related articles - All 3 versions
J Holst - Diabetes Obesity and Metabolism, 2008 - interscience.wiley.com Two incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like
peptide (GLP)-1, help control blood glucose levels by affecting plasma insulin levels in response
to oral glucose intake – this is known as the incretin effect. Incretins increase plasma ... Cited by 3 - Related articles - All 2 versions
FM Gribble - Diabetic Medicine, 2008 - pubmedcentral.nih.gov Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are
gastrointestinal hormones that play an important role in stimulating postprandial insulin release
from pancreatic β-cells. Agents that either mimic GLP-1 or prevent its degradation are ... Cited by 1 - Related articles - All 7 versions
JJ Meier, MA Nauck - Nature clinical practice. Endocrinology & …, 2008 - ncbi.nlm.nih.gov 1: Nat Clin Pract Endocrinol Metab. 2008 Nov;4(11):606-7. Epub 2008 Aug 26. Is secretion of
glucagon-like peptide-1 reduced in type 2 diabetes mellitus? Meier JJ, Nauck MA. Department
of Medicine I, St Josef-Hospital, Ruhr-University Bochum, Germany. ... Cited by 1 - Related articles - All 3 versions
GE Lim, M Xu, J Sun, T Jin, PL Brubaker - Endocrinology, 2009 - Endocrine Soc Rho GTPases, such as cell division cycle 42 (Cdc42) and ras-related C3 botulinum toxin substrate
1 (Rac1), have been identified as regulators of F-actin dynamics and hormone release from endocrine
cells; however, their role in secretion of the incretin hormone, glucagon-like peptide-1 ... Cited by 1 - Related articles - All 2 versions
